Evidence map›Paper›PMID 42587022›Full record

ReviewInternational journal of obesity (2005)2026

Obesity-associated unfolded protein response, oxidative stress, and NRF2 signaling.

Şeyma Özgür, Alessandro Medoro, Sergio Davinelli, Nicole Bender, Luciano Saso, Pelin Telkoparan-Akillilar

Abstract readReview
PubMed Publisher
In one paragraph

Review in International journal of obesity (2005), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Şeyma ÖzgürDepartment of Medical Biology and Genetics, Graduate School of Health Sciences, Gazi University, Ankara, Türkiye.ORCID http://orcid.org/0000-0001-9054-3233
Alessandro MedoroDepartment of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.ORCID http://orcid.org/0000-0002-6285-607X
Sergio DavinelliDepartment of Medicine and Health Sciences "V. Tiberio", University of Molise, Campobasso, Italy.ORCID http://orcid.org/0000-0003-2578-7199
Nicole BenderInstitute of Evolutionary Medicine, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-3838-587X
Luciano SasoFaculty of Pharmacy and Medicine, Sapienza University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0003-4530-8706
Pelin Telkoparan-AkillilarDepartment of Medical Biology and Genetics, Graduate School of Health Sciences, Gazi University, Ankara, Türkiye. pelintelkoparanakillilar@gazi.edu.tr.ORCID http://orcid.org/0000-0003-0337-0763

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity has become a major global health problem. It is characterized by increased body fat storage and is associated with excessive food intake. Although obesity is often thought of as a simple problem involving fat accumulation in the body, it is a complex disease that alters cellular defense systems and causes low-grade chronic inflammation, which can contribute metabolic syndrome. Even though obesity is an inflammatory disease, an increase in the formation of reactive oxygen species (ROS) is also observed due to excess nutrition. Excessive ROS production contributes to obesity progression and endoplasmic reticulum (ER) stress. In response to oxidative stress, cells activate antioxidant defense mechanisms either through unfolded protein response (UPR) pathways or via UPR-independent signaling pathways. Nuclear factor-erythroid 2-related factor-2 (NRF2) controls the transcription of multiple genes encoding antioxidant and cytoprotective proteins. NRF2 is of interest in obesity research as it can be activated with or without UPR elements and plays a role in the regulation of antioxidant response. Targeting NRF2 through multiple approaches has been shown to reduce or prevent obesity and obesity associated metabolic complications. This review examines the molecular mechanisms of NRF2 activation in obesity, with particular focus on its bidirectional crosstalk with the UPR and discusses the therapeutic implications of targeting this axis in obesity and its related metabolic dysfunction.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.